The Journal of Immunology, Vol 150, Issue 4 1195-1204, Copyright © 1993 by American Association of Immunologists

ARTICLES

Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C

N Isakov, D Galron, T Mustelin, GR Pettit and A Altman
Department of Microbiology and Immunology, Ben Gurion University of the Negev, Beer Sheva, Israel.

The bryostatins (Bryo) represent a group of immunomodulators that counteract the tumor-promoting effects of PMA. In contrast to the mitogenic effect of PMA on human peripheral blood T lymphocytes, Bryo was nonmitogenic and, furthermore, it inhibited PMA-induced T cell proliferation in a dose-dependent manner when added up to 2 days after PMA. Because both Bryo and PMA bind to, and activate, protein kinase C (PKC), we compared their effects on PKC expression and activity in human PBL or leukemic T cells (Jurkat). After treatment for 5 to 60 min, both Bryo and PMA were found to: a) activate PKC in vitro with similar dose-response curves; b) induce a nearly complete cytosol-to- membrane translocation of enzymatically active, Ca(2+)-dependent PKC and of distinct immunoreactive PKC isoforms in intact PBL; and c) stimulate similar patterns of protein phosphorylation. After a longer, 20-h treatment with PMA (20 nM), a considerable portion of PKC was still membrane-associated, and the total amount of immunoreactive PKC was not reduced considerably. In contrast, Bryo induced a marked loss of cellular immunoreactive PKC, including PKC-alpha and -beta. These results were paralleled by measurements of total cytosol- or membrane- associated PKC enzymatic activity. Thus, substantial PKC activity was associated with the particulate fraction of PMA-, but not Bryo- stimulated PBL. Furthermore, inhibition of PMA-induced T cell proliferation by Bryo also correlated with a reduction in the amount of cytosolic and membrane-bound immunoreactive PKC and enzymatic activity, demonstrating the dominance of Bryo over PMA. We propose that Bryo inhibits PMA-induced T cell proliferation by causing rapid degradation of PKC, reflecting a requirement of persistent PKC stimulation (lasting approximately 48 h) for the activation of human T cells and progression through the cell cycle.

This article has been cited by other articles:

				S. H. Choi, T. Hyman, and P. M. Blumberg Differential Effect of Bryostatin 1 and Phorbol 12-Myristate 13-Acetate on HOP-92 Cell Proliferation Is Mediated by Down-regulation of Protein Kinase C{delta}. Cancer Res., July 15, 2006; 66(14): 7261 - 7269. [Abstract] [Full Text] [PDF]

				Y. Do, V. L. Hegde, P. S. Nagarkatti, and M. Nagarkatti Bryostatin-1 Enhances the Maturation and Antigen-Presenting Ability of Murine and Human Dendritic Cells Cancer Res., September 15, 2004; 64(18): 6756 - 6765. [Abstract] [Full Text] [PDF]

				D. Rabah, S. Grant, C. Ma, and D. H. Conrad Bryostatin-1 Specifically Inhibits In Vitro IgE Synthesis J. Immunol., November 1, 2001; 167(9): 4910 - 4918. [Abstract] [Full Text] [PDF]

				M. A. Shah and G. K. Schwartz Cell Cycle-mediated Drug Resistance: An Emerging Concept in Cancer Therapy Clin. Cancer Res., August 1, 2001; 7(8): 2168 - 2181. [Abstract] [Full Text] [PDF]

				H.-Y. Wang, T. R. Bashore, Z. V. Tran, and E. Friedman Age-Related Decreases in Lymphocyte Protein Kinase C Activity and Translocation Are Reduced by Aerobic Fitness J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2000; 55(11): 545B - 551. [Abstract] [Full Text]

				J. E. Gschwend, W. R. Fair, and C. T. Powell Bryostatin 1 Induces Prolonged Activation of Extracellular Regulated Protein Kinases in and Apoptosis of LNCaP Human Prostate Cancer Cells Overexpressing Protein Kinase Calpha Mol. Pharmacol., June 1, 2000; 57(6): 1224 - 1234. [Abstract] [Full Text]

				Q. J. Wang, D. Bhattacharyya, S. Garfield, K. Nacro, V. E. Marquez, and P. M. Blumberg Differential Localization of Protein Kinase C delta by Phorbol Esters and Related Compounds Using a Fusion Protein with Green Fluorescent Protein J. Biol. Chem., December 24, 1999; 274(52): 37233 - 37239. [Abstract] [Full Text] [PDF]

				P. S. Lorenzo, K. Bogi, K. M. Hughes, M. Beheshti, D. Bhattacharyya, S. H. Garfield, G. R. Pettit, and P. M. Blumberg Differential Roles of the Tandem C1 Domains of Protein Kinase C {{delta}} in the Biphasic Down-Regulation Induced by Bryostatin 1 Cancer Res., December 1, 1999; 59(24): 6137 - 6144. [Abstract] [Full Text] [PDF]

				P. S. Lorenzo, K. Bogi, P. Acs, G. R. Pettit, and P. M. Blumberg The Catalytic Domain of Protein Kinase Cdelta Confers Protection from Down-regulation Induced by Bryostatin 1 J. Biol. Chem., December 26, 1997; 272(52): 33338 - 33343. [Abstract] [Full Text] [PDF]

				H.-W. Lee, L. Smith, G. R. Pettit, and J. B. Smith Bryostatin 1 and Phorbol Ester Down-Modulate Protein Kinase C-alpha and -epsilon via the Ubiquitin/Proteasome Pathway in Human Fibroblasts Mol. Pharmacol., March 1, 1997; 51(3): 439 - 447. [Abstract] [Full Text] [PDF]

				H.-W. Lee, L. Smith, G. R. Pettit, A. Vinitsky, and J. B. Smith Ubiquitination of Protein Kinase C-alpha and Degradation by the Proteasome J. Biol. Chem., August 30, 1996; 271(35): 20973 - 20976. [Abstract] [Full Text] [PDF]